FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

1236119 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
17 alpha-Hydroxyprogesterone aldolase deficiency Preferred (foundation metadata concept)
17 alpha-Hydroxyprogesterone aldolase deficiency (disorder) Preferred (foundation metadata concept)
17 alpha-hydroxyprogesterone Preferred (foundation metadata concept)
17 alpha-hydroxyprogesterone Acceptable (foundation metadata concept)
17 alpha-hydroxyprogesterone (substance) Preferred (foundation metadata concept)
17 beta-estradiol Preferred (foundation metadata concept)
17 beta-estradiol (substance) Preferred (foundation metadata concept)
17 beta-estradiol preparation Preferred (foundation metadata concept)
17 beta-estradiol preparation (product) Preferred (foundation metadata concept)
17 beta-hydroxysteroid dehydrogenase Acceptable (foundation metadata concept)
17,18,21-trihydroxypregn-4-ene-3,11,20-trione Acceptable (foundation metadata concept)
17,21-dihydroxypregnenolone Preferred (foundation metadata concept)
17,21-dihydroxypregnenolone (substance) Preferred (foundation metadata concept)
17,21-hydroxyprogesterone Acceptable (foundation metadata concept)
17-Beta-estriol Preferred (foundation metadata concept)
17-Beta-estriol (substance) Preferred (foundation metadata concept)
17-Hydroxycorticosteroid Preferred (foundation metadata concept)
17-Hydroxycorticosteroid (substance) Preferred (foundation metadata concept)
17-Hydroxyketosteroids measurement Preferred (foundation metadata concept)
17-Hydroxyketosteroids measurement (procedure) Preferred (foundation metadata concept)
17-Hydroxypregnenolone measurement Preferred (foundation metadata concept)
17-Hydroxypregnenolone measurement (procedure) Preferred (foundation metadata concept)
17-KGS measurement Acceptable (foundation metadata concept)
17-KS measurement Acceptable (foundation metadata concept)
17-KS measurement, fractionation Acceptable (foundation metadata concept)
17-KSR deficiency Acceptable (foundation metadata concept)
17-Ketogenic steroid Preferred (foundation metadata concept)
17-Ketogenic steroid (substance) Preferred (foundation metadata concept)
17-Ketogenic steroids measurement Preferred (foundation metadata concept)
17-Ketogenic steroids measurement (procedure) Preferred (foundation metadata concept)
17-Ketosteroid reductase deficiency Acceptable (foundation metadata concept)
17-Ketosteroids Acceptable (foundation metadata concept)
17-Ketosteroids measurement Preferred (foundation metadata concept)
17-Ketosteroids measurement (procedure) Preferred (foundation metadata concept)
17-Ketosteroids measurement, fractionation, urine Preferred (foundation metadata concept)
17-Ketosteroids measurement, fractionation, urine (procedure) Preferred (foundation metadata concept)
17-Ketosteroids measurement, total Preferred (foundation metadata concept)
17-Ketosteroids measurement, total (procedure) Preferred (foundation metadata concept)
17-O-deacetylvindoline O-acetyltransferase Preferred (foundation metadata concept)
17-O-deacetylvindoline O-acetyltransferase (substance) Preferred (foundation metadata concept)
17-OHCS measurement Acceptable (foundation metadata concept)
17-Oxogenic steroid Acceptable (foundation metadata concept)
17-Oxosteroid Preferred (foundation metadata concept)
17-Oxosteroid (substance) Preferred (foundation metadata concept)
17-alpha-18,21-trihydroxypregn-4-ene-3,20-dione Acceptable (foundation metadata concept)
17-alpha-hydroxypregnenolone Acceptable (foundation metadata concept)
17-beta estradiol Acceptable (foundation metadata concept)
17-hydrocorticosteroid Acceptable (foundation metadata concept)
17-hydroxycorticoid Acceptable (foundation metadata concept)
17-hydroxycorticosteroid Preferred (foundation metadata concept)
17-hydroxycorticosteroid (substance) Preferred (foundation metadata concept)
17-hydroxycorticosteroid measurement Preferred (foundation metadata concept)
17-hydroxycorticosteroid measurement (procedure) Preferred (foundation metadata concept)
17-hydroxylase Acceptable (foundation metadata concept)
17-hydroxypregnenolone Preferred (foundation metadata concept)
17-hydroxypregnenolone (substance) Preferred (foundation metadata concept)
17-hydroxyprogesterone Preferred (foundation metadata concept)
17-hydroxyprogesterone (substance) Preferred (foundation metadata concept)
17-ketogenic steroid Preferred (foundation metadata concept)
17-ketogenic steroid (substance) Preferred (foundation metadata concept)
17-ketosteroid Preferred (foundation metadata concept)
17-ketosteroid (substance) Preferred (foundation metadata concept)
17-ketosteroid in urine specimen above reference range Acceptable (foundation metadata concept)
17-ketosteroid in urine specimen above reference range (finding) Preferred (foundation metadata concept)
17-oxosteroid Acceptable (foundation metadata concept)
17-oxosteroids Acceptable (foundation metadata concept)
17.7 Preferred (foundation metadata concept)
17.7 (qualifier value) Preferred (foundation metadata concept)
17.8 Preferred (foundation metadata concept)
17.8 (qualifier value) Preferred (foundation metadata concept)
17/22 Preferred (foundation metadata concept)
17/25 Preferred (foundation metadata concept)
170 Preferred (foundation metadata concept)
170 (qualifier value) Preferred (foundation metadata concept)
170-Hf Acceptable (foundation metadata concept)
17000 Preferred (foundation metadata concept)
17000 (qualifier value) Preferred (foundation metadata concept)
171-Hf Acceptable (foundation metadata concept)
172 Preferred (foundation metadata concept)
172 (qualifier value) Preferred (foundation metadata concept)
172-Hf Acceptable (foundation metadata concept)
172.5 Preferred (foundation metadata concept)
172.5 (qualifier value) Preferred (foundation metadata concept)
1720 Preferred (foundation metadata concept)
1720 (qualifier value) Preferred (foundation metadata concept)
173-Hf Acceptable (foundation metadata concept)
173-Ta Acceptable (foundation metadata concept)
174 Preferred (foundation metadata concept)
174 (qualifier value) Preferred (foundation metadata concept)
174-Hf Acceptable (foundation metadata concept)
174-Ta Acceptable (foundation metadata concept)
175 Preferred (foundation metadata concept)
175 (qualifier value) Preferred (foundation metadata concept)
175-Hf Acceptable (foundation metadata concept)
175-Ta Acceptable (foundation metadata concept)
175-Yb Acceptable (foundation metadata concept)
175.439 Preferred (foundation metadata concept)
175.439 (qualifier value) Preferred (foundation metadata concept)
1750 Preferred (foundation metadata concept)
1750 (qualifier value) Preferred (foundation metadata concept)
17500 Preferred (foundation metadata concept)

Start Previous Page 73 of 12362 Next End

Reference Sets

Reference set descriptor

Back to Start